S1007
Breast Cancer
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of 25 or less.
Key Team Members
Principal Investigator
Research Coordinator
Katharine "Kate" Madden
